A detailed history of Principal Securities, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Principal Securities, Inc. holds 37,596 shares of BMY stock, worth $2.21 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
37,596
Previous 27,944 34.54%
Holding current value
$2.21 Million
Previous $1.16 Billion 67.62%
% of portfolio
0.05%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$39.66 - $51.75 $382,798 - $499,491
9,652 Added 34.54%
37,596 $1.95 Billion
Q2 2024

Jul 31, 2024

BUY
$40.25 - $52.99 $127,632 - $168,031
3,171 Added 12.8%
27,944 $1.16 Billion
Q1 2024

May 10, 2024

BUY
$47.98 - $54.4 $123,404 - $139,916
2,572 Added 11.59%
24,773 $1.34 Billion
Q4 2023

Feb 07, 2024

BUY
$48.48 - $57.85 $1.08 Million - $1.28 Million
22,201 New
22,201 $1.14 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.